Frontlight ResearchEarly access
Trial site
Prague
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma4 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Giant cell arteritis1 trial
- Metastatic breast cancer1 trial
- Multiple sclerosis1 trial
- Nephrotic syndrome1 trial
- Polymyalgia rheumatica1 trial
- Pompe disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 1/21 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Enrolling by invitation2 trials
- Terminated1 trial
- Lead sponsor
- Sanofi10 trials
- Genzyme, a Sanofi Company1 trial
Running trials
Recruiting
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Giant cell arteritis1 recruiting
- Multiple myeloma1 recruiting
- Nephrotic syndrome1 recruiting
- Polymyalgia rheumatica1 recruiting
- Pompe disease1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 15 Nov 2026